The optimal infusion rate of medium-chain triglyceride/long-chain triglyceride emulsion (MCT/LCT) during plasma insulin clamp
The optimal infusion rate of medium-chain triglyceride/long-chain triglyceride emulsion (MCT/LCT) during plasma insulin clamp
批准号:
08671355
负责人:
MIKI Chikao
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
As medium-chain triglyceride emulsions (MCT) are more rapidly hydrolyzed than long-chain triglyceride emulsions (LCT), MCT/LCT tends to be infused faster than LCT.The purpose of this research project was to determine the most appropriate infusion rate for MCT/LCT to stabilize plasma concentrations of triglyceride (TG), being equivalent to the optimal infusion rate of the emulsion. A TG clamp was set up by raising the mean (]SY.+-。[) s.d.concentrations of TG in plasma, being 1.08 (]SY.+-。[) 0.18 delta-mmol/l for LCT,and 1.65 (]SY.+-。[) 0.31 delta-mmol/l for MCT/LCT after a 50-min priming infusion of each emulsion. Thereafter, the infusion rate of lipid was controlled every 10 min to maintain a steady concentration of TG for a period of 150 min. A constant infusion of glucose at 0.32 g/kg/h was given for the test period. The weight-based rate of the infusion to maintain a steady state of plasma TG concentrations did not differ between MCT/LCT and LCT,being 0.125 (]SY.+-。[) 0.013 versus 0.117 (]SY.+-。[) 0.021 g/kg/h, while the molar-based infusion rate was 0.203 (]SY.+-。[) 0.021 mmol/kg/h for MCT/LCT and 0.132 (]SY.+-。[) 0.023 mmol/kg/h for LCT.These results suggest that although 54% more molar MCT/LCT can be hydrolyzed during a constant infusion, MCT/LCT should not be infused at a rate faster than 0.1 g/kg/h under a steady state.Apolipoprotein C-II (apo C-II) is essential for TG hydrolysis. It was investigated in vitro if the amounts of apo C-II acquired by lipid particles are different between MCT and LCT.The results demonstrated that there was no differences in the amounts of in vitro transfer of apo C-II from high-density lipoprotein to lipid particles between MCT and LCT.However, it was suggrested that MCT-TGs require less amounts of apo C-II than LCT in the process of hydrolysis, since the mean amount of apo C-II acquired by one micro-mol of MCT-TG was less than that acquired by one micro-mol of LCT-TG.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Iriyama K.: "The metabolic distinctiveness of emulsified lipid particles in the bloodstream." Surg Today. 26. 673-678 (1996)
Iriyama K.:“血液中乳化脂质颗粒的代谢独特性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Keiji Iriyama: "Elimination of fat emulsion particles from plasma during glucose infusion." British Journal of Surgery. 83. 946-948 (1996)
Keiji Iriyama:“在葡萄糖输注过程中消除血浆中的脂肪乳颗粒。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Iriyama K,Miki C,Inoue T,Kawarabayashi N,Urata H,Shigemori C.: "Constant infusion rates of lipid emulsions to stabilize plasma concentrations ; Medium-chain triglyceride/long-chain triglyceride (MCT/LCT) versus LCT." Surg Today. 28 : no.3(in press). (1998
Iriyama K、Miki C、Inoue T、Kawarabayashi N、Urata H、Shigemori C.:“恒定的脂质乳剂输注速率以稳定血浆浓度;中链甘油三酯/长链甘油三酯 (MCT/LCT) 与 LCT。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
入山圭二: "MCT含有脂肪乳剤の代謝特性と将来展望" 医学のあゆみ. 183. 743-746 (1997)
Keiji Iriyama:“含 MCT 的脂肪乳剂的代谢特性和未来前景”医学史 183. 743-746 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Keiji Iriyama: "Elimination rate of fat emlsion particles from plasma in Japanese subjects as determined by a triglyceride clamp technique." Nutrition. 12. 79-82 (1996)
Keiji Iriyama:“通过甘油三酯钳技术测定日本受试者血浆中脂肪乳颗粒的消除率。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Therapeutic potential for cancer cachexia by modulating the tumor-host inflammatory interactions
-
批准号:21591665
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:MIKI Chikao
-
依托单位:
Establishment of a novel anti-tumour therapy by regulating the affinity of tumour growth cytokines for their receptors
-
批准号:15591339
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2003
-
负责人:MIKI Chikao
-
依托单位:
The role of MAD2 gene in chromosomal instability in colorectal cancers
-
批准号:12671221
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:MIKI Chikao
-
依托单位:
海外基金